查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1578381

心臟節律器市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2033年

Cardiac Pacemaker Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 163 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research對心臟起搏器市場進行了全面分析，深入了解其複雜的動態和未來軌跡。本報告深入探討了市場趨勢、成長催化劑、障礙和新興模式，並提供了2024-2033年有價值的統計資料和預測。

主要見解

  • 市場規模（2024年）：39.238億美元
  • 市場預測金額（2033年）：54.01億美元
  • 世界成長率（CAGR2024年～2033年）：3.6%

調查範圍：

心臟節律器市場包括用於調節心律不整患者心律的植入式心律調節器和體外心律調節器。這些設備在治療心搏過緩、心臟衰竭和心房顫動等心臟疾病方面發揮重要作用。心律調節器是一種救生醫療設備，可透過電脈衝幫助維持規律的心跳。該市場服務於醫院、門診手術中心和心臟專科中心，重點關注先進的微創手術和長期設備有效性。

推動市場成長的因素：

全球心臟節律器市場由幾個關鍵因素驅動。人口老化和心血管疾病盛行率的增加是市場需求的主要驅動力。久坐生活方式的增加以及肥胖和糖尿病等相關風險因素導致心臟相關疾病激增，進一步推動市場成長。此外，心律調節器技術的不斷進步，包括無線、無引線心律調節器和 MRI 相容設備，改善患者的治療效果並提高採用率。隨著先進醫療保健的普及，醫療保健支出的增加（尤其是在新興國家）也推動了市場成長。

市場抑制要因：

儘管成長前景廣闊，但心臟節律器市場仍面臨阻礙擴張的挑戰。先進起搏器設備和外科手術的高成本限制了醫療基礎設施低度開發地區的市場滲透率。此外，對潛在設備故障和導線移位和感染等併發症的擔憂也導致患者和醫生猶豫不決。新起搏器型號所需的嚴格監管批准進一步減緩了新進入者的創新和市場進入。

市場機會：

心臟節律器市場存在多個有利的成長機會。技術進步，特別是無線心律調節器和無引線心律調節器的進步，為創新和市場成長開闢了新的途徑。這些發展最大限度地減少了患者的不適，並降低了與傳統起搏器相關的併發症的風險。此外，對遠端監測解決方案不斷成長的需求推動人工智慧（AI）和物聯網（IoT）技術整合到心律調節器設備中，使醫療保健提供者能夠即時監測患者的心臟健康狀況。亞太地區和拉丁美洲的新興市場擁有快速發展的醫療基礎設施，隨著心血管治療機會的改善，具有巨大的成長潛力。

關鍵問題

  • 推動心臟節律器市場全球成長的關鍵因素是什麼？
  • 技術進步如何影響新起搏器型號的開發？
  • 市場參與者面臨哪些主要挑戰以及如何應對這些挑戰？
  • 哪些人口統計和地區對於起搏器提供者而言最具成長潛力？
  • 領先的公司採取哪些策略來使心律調節器在競爭格局中脫穎而出？

目次

第1章 執行摘要

第2章 市場介紹

  • 市場定義
  • 市場分類

第3章 全球心臟節律器市場分析場景

  • 市場規模（百萬美元）和預測
  • 市場概要

第4章 市場動態

  • 宏觀經濟因素
  • 促進要因
    • 供給側
    • 需要側
  • 抑制要因
  • 機會
  • 償付和監管情景

第5章 全球心臟節律器市場分析與預測：依產品

  • 簡介
  • 基點佔有率（BPS）分析：依產品類型
  • 年成長預測：依產品類型分類
  • 市場價值預測：依產品分類，2024-2033年
    • 植入式心臟節律器
      • 單腔起搏器
      • 雙腔心律調節器
      • 雙心室節律器
    • 體外心臟節律器
  • 市場吸引力：依產品分類

第6章 全球心臟節律器市場分析與預測：依最終用戶

  • 簡介
  • 基點佔有率（BPS）分析：依最終用戶分類
  • 年成長預測：依最終用戶
  • 2024-2033年市場價值預測：依最終用戶
    • 病院
    • 門診手術中心
  • 市場吸引力：依最終用戶

第7章 全球心臟節律器市場分析與預測：依地區

  • 基點佔有率（BPS）分析：依地區
  • 年成長預測：依地區
  • 市場價值預測：依地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東、非洲
  • 市場吸引力：依地區

第8章 北美心臟節律器市場分析與預測

第9章 拉丁美洲心臟節律器市場分析與預測

第10章 歐洲心臟節律器市場分析及預測

第11章 亞太心臟節律器市場分析與預測

  • 簡介
    • 基點佔有率（BPS）分析：依國家分類
    • 年成長預測：依國家劃分
  • 市場價值預測：依產品分類，2024-2033年
    • 植入式心臟節律器
      • 單腔起搏器
      • 雙腔心律調節器
      • 雙心室節律器
    • 體外心臟節律器
  • 市場價值預測：依最終用戶劃分，2024-2033年
    • 病院
    • 門診手術中心
  • 市場價值預測：依國家劃分，2024-2033年
    • 中國
    • 印度
    • 日本
    • 澳洲/紐西蘭
    • 亞太地區其他國家
  • 市場吸引力分析
  • 顯著趨勢

第12章 中東與非洲心臟節律器市場分析與預測

第13章 競爭情勢

  • 競爭儀表板
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • BIOTRONIK SE &Co. KG
    • Boston Scientific Corporation
    • Medtronic
    • St. Jude Medical Inc.
    • LivaNova PLC.
    • lepumedical.com
    • Osypka Medical GmbH
    • Pacetronix.com
    • MEDICOWEB

第14章 使用的先決條件與縮寫

第15章 研究方法

簡介目錄
Product Code: PMRREP12382

Persistence Market Research offers a comprehensive analysis of the Cardiac Pacemaker Market, providing insights into its complex dynamics and future trajectory. This report delves into market trends, growth catalysts, obstacles, and emerging patterns, presenting valuable statistics and projections from 2024 to 2033.

Key Insights:

  • Market Size (2024): USD 3923.8 Mn
  • Projected Market Value (2033): USD 5401 Mn
  • Global Growth Rate (CAGR 2024-2033): 3.6%

Report Scope:

The Cardiac Pacemaker Market comprises implantable and external pacemakers used to regulate heart rhythm in patients with arrhythmias. These devices play a critical role in the treatment of heart conditions such as bradycardia, heart failure, and atrial fibrillation. Pacemakers are life-saving medical devices that help in maintaining a regular heartbeat through electrical pulses. The market serves hospitals, ambulatory surgical centers, and specialized cardiac care centers, with a growing focus on advanced, minimally invasive procedures and long-lasting device efficacy.

Market Growth Drivers:

The global Cardiac Pacemaker Market is driven by several key factors. An aging population with an increasing prevalence of cardiovascular diseases is a major driver of market demand. The rise in sedentary lifestyles and associated risk factors, such as obesity and diabetes, has led to a surge in heart-related conditions, further fueling market growth. Moreover, continuous advancements in pacemaker technology-such as wireless, leadless pacemakers and MRI-compatible devices-enhance patient outcomes and drive adoption rates. Increasing healthcare spending, particularly in emerging economies, also supports market growth, as access to advanced medical treatments becomes more widespread.

Market Restraints:

Despite promising growth prospects, the Cardiac Pacemaker Market faces challenges that could hinder its expansion. High costs associated with advanced pacemaker devices and surgical procedures limit market penetration in regions with underdeveloped healthcare infrastructure. Additionally, concerns about potential device malfunctions and complications, such as lead displacement or infections, create hesitation among patients and physicians. Stringent regulatory approvals required for new pacemaker models further slow down innovation and market entry for new players.

Market Opportunities:

The Cardiac Pacemaker Market presents several lucrative growth opportunities. Technological advancements, particularly in wireless and leadless pacemakers, open up new avenues for innovation and market growth. These developments minimize patient discomfort and reduce the risk of complications associated with traditional pacemakers. Additionally, increasing demand for remote monitoring solutions provides opportunities for market players to integrate artificial intelligence (AI) and Internet of Things (IoT) technologies into pacemaker devices, allowing healthcare providers to monitor patients' heart health in real time. Emerging markets in Asia-Pacific and Latin America, where healthcare infrastructure is rapidly evolving, offer significant growth potential as access to cardiovascular treatments improves.

Key Questions Answered:

  • What are the primary factors driving the growth of the Cardiac Pacemaker Market globally?
  • How are technological advancements influencing the development of new pacemaker models?
  • What are the key challenges facing market participants, and how can they be addressed?
  • Which demographic groups and geographic regions present the highest growth potential for pacemaker providers?
  • What strategies are leading companies employing to differentiate their pacemaker offerings in the competitive medical device landscape?

Competitive Intelligence and Business Strategy:

Leading players in the Cardiac Pacemaker Market, including pacemaker manufacturers and healthcare providers, focus on product innovation, safety enhancements, and geographic expansion to gain a competitive edge. Companies invest heavily in research and development to create next-generation pacemakers that are smaller, more efficient, and compatible with advanced diagnostic tools such as MRI. Strategic partnerships with hospitals, academic institutions, and technology firms enable market players to accelerate innovation, streamline regulatory processes, and expand their presence in key regions.

Emphasis on after-sales services, including patient monitoring, product recalls, and technical support, further enhances brand reputation and fosters long-term relationships with healthcare providers and patients. Continuous improvements in product durability, battery life, and patient safety are central to market players' strategies as they seek to maintain competitive advantage.

Key Companies Profiled:

  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Medtronic
  • St. Jude Medical Inc.
  • LivaNova PLC.
  • lepumedical.com
  • Osypka Medical GmbH
  • Pacetronix.com
  • MEDICOWEB
  • Others.

Market Segmentation:

By Type:

  • Implantable Pacemakers
  • External Pacemakers

By Product:

  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Cardiac Pacemaker Market Analysis Scenario

  • 3.1. Market Size (US$ Mn) and Forecast
  • 3.2. Market Overview

4. Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Opportunity
  • 4.5. Reimbursement and Regulatory Scenario

5. Global Cardiac Pacemaker Market Analysis and Forecasts, By Product

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Product Type
  • 5.3. Y-o-Y Growth Projections By Product Type
  • 5.4. Market Value Forecast By Product, 2024-2033
    • 5.4.1. Implantable Cardiac Pacemaker
      • 5.4.1.1. Single Chamber Pacemaker
      • 5.4.1.2. Dual Chamber Pacemaker
      • 5.4.1.3. Biventricular Pacemaker
    • 5.4.2. External Cardiac Pacemaker
  • 5.5. Market Attractiveness By Product

6. Global Cardiac Pacemaker Market Analysis and Forecasts, By End User

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By End User
  • 6.3. Y-o-Y Growth Projections By End User
  • 6.4. Market Value Forecast By End User, 2024-2033
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centers
  • 6.5. Market Attractiveness By End User

7. Global Cardiac Pacemaker Market Analysis and Forecasts, By Region

  • 7.1. Basis Point Share (BPS) Analysis By Region
  • 7.2. Y-o-Y Growth Projections By Region
  • 7.3. Market Value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. APAC
    • 7.3.5. MEA
  • 7.4. Market Attractiveness By Region

8. North America Cardiac Pacemaker Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Country
    • 8.1.2. Y-o-Y Growth Projections By Country
  • 8.2. Market Value Forecast By Product, 2024-2033
    • 8.2.1. Implantable Cardiac Pacemaker
      • 8.2.1.1. Single Chamber Pacemaker
      • 8.2.1.2. Dual Chamber Pacemaker
      • 8.2.1.3. Biventricular Pacemaker
    • 8.2.2. External Cardiac Pacemaker
  • 8.3. Market Value Forecast By End User, 2024-2033
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
  • 8.4. Market Value Forecast By Country, 2024-2033
    • 8.4.1. US
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Product
    • 8.5.2. By End User
    • 8.5.3. By Country
  • 8.6. Prominent Trends

9. Latin America Cardiac Pacemaker Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
  • 9.2. Market Value Forecast By Product, 2024-2033
    • 9.2.1. Implantable Cardiac Pacemaker
      • 9.2.1.1. Single Chamber Pacemaker
      • 9.2.1.2. Dual Chamber Pacemaker
      • 9.2.1.3. Biventricular Pacemaker
    • 9.2.2. External Cardiac Pacemaker
  • 9.3. Market Value Forecast By End User, 2024-2033
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
  • 9.4. Market Value Forecast By Country, 2024-2033
    • 9.4.1. Argentina
    • 9.4.2. Brazil
    • 9.4.3. Mexico
    • 9.4.4. Rest of Latin America
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End User
    • 9.5.3. By Country
  • 9.6. Prominent Trends

10. Europe Cardiac Pacemaker Market Analysis and Forecast

  • 10.1.Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
  • 10.2.Market Value Forecast By Product, 2024-2033
    • 10.2.1. Implantable Cardiac Pacemaker
      • 10.2.1.1. Single Chamber Pacemaker
      • 10.2.1.2. Dual Chamber Pacemaker
      • 10.2.1.3. Biventricular Pacemaker
    • 10.2.2. External Cardiac Pacemaker
  • 10.3.Market Value Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Ambulatory Surgical Centers
  • 10.4.Market Value Forecast By Country, 2024-2033
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Poland
    • 10.4.7. Russia
    • 10.4.8. Rest Of Europe
  • 10.5.Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By End User
    • 10.5.3. By Country
  • 10.6. Prominent Trends

11. APAC Cardiac Pacemaker Market Analysis and Forecast

  • 11.1.Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.2.Market Value Forecast By Product, 2024-2033
    • 11.2.1. Implantable Cardiac Pacemaker
      • 11.2.1.1. Single Chamber Pacemaker
      • 11.2.1.2. Dual Chamber Pacemaker
      • 11.2.1.3. Biventricular Pacemaker
    • 11.2.2. External Cardiac Pacemaker
  • 11.3.Market Value Forecast By End User, 2024-2033
    • 11.3.1. Hospitals
    • 11.3.2. Ambulatory Surgical Centers
  • 11.4.Market Value Forecast By Country, 2024-2033
    • 11.4.1. China
    • 11.4.2. India
    • 11.4.3. Japan
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest OF APAC
  • 11.5.Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By End User
    • 11.5.3. By Country
  • 11.6. Prominent Trends

12. MEA Cardiac Pacemaker Market Analysis and Forecast

  • 12.1.Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.2.Market Value Forecast By Product, 2024-2033
    • 12.2.1. Implantable Cardiac Pacemaker
      • 12.2.1.1. Single Chamber Pacemaker
      • 12.2.1.2. Dual Chamber Pacemaker
      • 12.2.1.3. Biventricular Pacemaker
    • 12.2.2. External Cardiac Pacemaker
  • 12.3.Market Value Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centers
  • 12.4.Market Value Forecast By Country, 2024-2033
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of MEA
  • 12.5.Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By End User
    • 12.5.3. By Country
  • 12.6. Prominent Trends

13. Competition Landscape

  • 13.1. Competition Dashboard
  • 13.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.2.1. BIOTRONIK SE & Co. KG
    • 13.2.2. Boston Scientific Corporation
    • 13.2.3. Medtronic
    • 13.2.4. St. Jude Medical Inc.
    • 13.2.5. LivaNova PLC.
    • 13.2.6. lepumedical.com
    • 13.2.7. Osypka Medical GmbH
    • 13.3.8. Pacetronix.com
    • 13.3.9. MEDICOWEB

14. Assumptions and Acronyms Used

15. Research Methodology